<SEC-DOCUMENT>0001140361-25-002636.txt : 20250131
<SEC-HEADER>0001140361-25-002636.hdr.sgml : 20250131
<ACCEPTANCE-DATETIME>20250131091505
ACCESSION NUMBER:		0001140361-25-002636
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250131

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aimei Health Technology Co., Ltd.
		CENTRAL INDEX KEY:			0001979005
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94248
		FILM NUMBER:		25576160

	BUSINESS ADDRESS:	
		STREET 1:		10 EAST 53RD STREET
		STREET 2:		SUITE 3001
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		34 678 035200

	MAIL ADDRESS:	
		STREET 1:		10 EAST 53RD STREET
		STREET 2:		SUITE 3001
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WOLVERINE ASSET MANAGEMENT LLC
		CENTRAL INDEX KEY:			0001279891
		ORGANIZATION NAME:           	
		IRS NUMBER:				020611276

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		175 W. JACKSON
		STREET 2:		SUITE 340
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60064
		BUSINESS PHONE:		3128844400

	MAIL ADDRESS:	
		STREET 1:		175 WEST JACKSON
		STREET 2:		SUITE 340
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<previousAccessionNumber>0001140361-24-043487</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001279891</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>1</amendmentNo>
<securitiesClassTitle>Ordinary Shares, $0.0001 par value per share</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001979005</issuerCik>
<issuerName>Aimei Health Technology Co., Ltd.</issuerName>
<issuerCusip>G01341109</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>10 East 53rd Street, Suite 3001</com:street1>
<com:city>New York</com:city>
<com:stateOrCountry>NY</com:stateOrCountry>
<com:zipCode>10022</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>WOLVERINE ASSET MANAGEMENT LLC</reportingPersonName>
<citizenshipOrOrganization>IL</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>654039</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>654039</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>654039</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>7.25</classPercent>
<typeOfReportingPerson>IA</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Wolverine Trading Partners, Inc.</reportingPersonName>
<citizenshipOrOrganization>IL</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>654039</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>654039</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>654039</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>7.25</classPercent>
<typeOfReportingPerson>CO</typeOfReportingPerson>
<typeOfReportingPerson>HC</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Wolverine Holdings, L.P.</reportingPersonName>
<citizenshipOrOrganization>IL</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>654039</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>654039</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>654039</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>7.25</classPercent>
<typeOfReportingPerson>HC</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Christopher L. Gust</reportingPersonName>
<citizenshipOrOrganization>IL</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>654039</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>654039</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>654039</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>7.25</classPercent>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<typeOfReportingPerson>HC</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Robert R. Bellick</reportingPersonName>
<citizenshipOrOrganization>IL</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>654039</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>654039</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>654039</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>7.25</classPercent>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<typeOfReportingPerson>HC</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>Aimei Health Technology Co., Ltd.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>10 East 53rd Street, Suite 3001, New York, New York, 10022</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>Wolverine Asset Management, LLC
Wolverine Holdings, L.P.
Wolverine Trading Partners, Inc.
Christopher L. Gust
Robert R. Bellick</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>c/o Wolverine Asset Management, LLC
175 West Jackson Boulevard, Suite 340
Chicago, IL 60604</principalBusinessOfficeOrResidenceAddress>
<citizenship>Wolverine Asset Management, LLC - Illinois
Wolverine Holdings, L.P. - Illinois
Wolverine Trading Partners, Inc. - Illinois
Christopher L. Gust - U.S. Citizen
Robert R. Bellick - U.S. Citizen</citizenship>
</item2>
<item3>
<notApplicableFlag>N</notApplicableFlag>
<typeOfPersonFiling>IA</typeOfPersonFiling>
<typeOfPersonFiling>HC</typeOfPersonFiling>
</item3>
<item4>
<amountBeneficiallyOwned>Wolverine Asset Management, LLC ("WAM") is an investment adviser and has voting and disposition power over 654,039 of the Issuer's Ordinary Shares. The sole member and manager of WAM is Wolverine Holdings, L.P. ("Wolverine Holdings"). Robert R. Bellick and Christopher L. Gust may be deemed to control Wolverine Trading Partners, Inc. ("WTP"), the general partner of Wolverine Holdings.</amountBeneficiallyOwned>
<classPercent>WAM may be deemed the beneficial owner of 7.25% of the Issuer's outstanding Ordinary Shares and each of Wolverine Holdings, WTP, Mr. Bellick, and Mr. Gust may be deemed the beneficial owner of 7.25% of the Issuer's outstanding Ordinary Shares. Percentages were calculated by dividing the number of shares beneficially owned by each reporting person by 9,026,000 (the number of Ordinary Shares as of November 13, 2024 as reported in the Issuer's Form 10-Q for September 30, 2024).</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>0</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>WAM has shared power to vote, or direct the vote of, 654,039 of the Issuer's Ordinary Shares, and each of Wolverine Holdings, WTP, Mr. Bellick, and Mr. Gust has shared power to vote or direct the vote of 654,039 of the Issuer's Ordinary Shares, in each case as set forth in Item 4(a) above.</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>WAM has shared power to dispose, or direct the disposition of, 654,039 of the Issuer's Ordinary Shares, and each of Wolverine Holdings, WTP, Mr. Bellick, and Mr. Gust has shared power to dispose, or direct the disposition, of 654,039 of the Issuer's Ordinary Shares, in each case as set forth in Item 4(a) above.</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>Y</notApplicableFlag>
</item5>
<item6>
<notApplicableFlag>N</notApplicableFlag>
<ownershipMoreThan5PercentOnBehalfOfAnotherPerson>Wolverine Flagship Fund Trading Limited is known to have the right to receive the receipt of dividends from, or the proceeds from the sale of, the shares of common stock covered by this statement which may be deemed to beneficially be owned by WAM.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
</item6>
<item7>
<notApplicableFlag>N</notApplicableFlag>
<subsidiaryIdentificationAndClassification>See Item 4(a) above.</subsidiaryIdentificationAndClassification>
</item7>
<item8>
<notApplicableFlag>Y</notApplicableFlag>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>WOLVERINE ASSET MANAGEMENT LLC</reportingPersonName>
<signatureDetails>
<signature>/s/ Kenneth L. Nadel</signature>
<title>Kenneth L. Nadel, Chief Operating Officer</title>
<date>01/28/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>Wolverine Trading Partners, Inc.</reportingPersonName>
<signatureDetails>
<signature>/s/ Christopher L. Gust</signature>
<title>Christopher L. Gust, Authorized Signatory</title>
<date>01/28/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>Wolverine Holdings, L.P.</reportingPersonName>
<signatureDetails>
<signature>/s/ Christopher L. Gust</signature>
<title>Christopher L. Gust, Managing Director</title>
<date>01/28/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>Christopher L. Gust</reportingPersonName>
<signatureDetails>
<signature>/s/ Christopher L. Gust</signature>
<title>Christopher L. Gust</title>
<date>01/28/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>Robert R. Bellick</reportingPersonName>
<signatureDetails>
<signature>/s/ Robert R. Bellick</signature>
<title>Robert R. Bellick</title>
<date>01/28/2025</date>
</signatureDetails>
</signatureInformation>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
